OLMA — Olema Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapNeutral

Annual balance sheet for Olema Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	287	204	262	434	505
Net Total Receivables	—	0.319	0.673	2.12	3.14
Prepaid Expenses
Total Other Current Assets
Total Current Assets	291	209	267	438	515
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	4.72	3.98	3.26	2.06	1.42
Other Long Term Assets
Total Assets	296	216	277	451	533
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	9.02	16.5	21.6	41.8	51.8
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	11.4	18.1	23.1	42	54.9
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	285	198	254	409	479
Total Liabilities & Shareholders' Equity	296	216	277	451	533
Total Common Shares Outstanding